Bob Charles on Pyramid One Radio Network has been saying over and over and over, THIS IS KILLING PEOPLE
BUT ! As much as we say do not eat GMO food the World Population is Still doing it.
Look at People who died Recently, Young People Right !
KEEP UP FEEDING YOUR KIDS AND YOURSELF GMO FOOD AND YOUR NEXT ! RIP
BUT WHAT DO YOU CARE YOU CAN'T READ !
View photos
Monsanto
logo is displayed on a screen where the stock is traded on the floor of
the New York Stock Exchange (NYSE) in New York City, U.S. on May 9,
2016. REUTERS/Brendan McDermid/File Photo
(Reuters)
- U.S. seeds and agrochemicals company Monsanto Co <MON.N>, which
is being bought by Germany's Bayer <AG BAYGn.DE> for $66 billion,
swung to a quarterly profit, helped by higher demand from South
America. Sales
of soybean seeds and traits jumped 37 percent as more farmers in South
America sowed the company's genetically modified soybean seed Intacta
RR2 Pro.
Monsanto
agreed in September to a sweetened $128-per-share offer from Bayer
that, if approved by regulators, would create a company commanding more
than a quarter of the world market for seeds and pesticides. Monsanto,
known for its genetically engineered corn and Roundup herbicide, did
not offer any update on regulatory approvals or potential divestitures
related to the Bayer deal. Bayer
and Monsanto have said they are confident that the deal will pass
regulatory scrutiny. Bayer has said it is committed to divest up to $1.6
billion of its portfolio to win approval.
Net
profit attributable to Monsanto was $29 million, or 7 cents per share,
in the first quarter ended Nov. 30, compared with a loss of $253
million, or 56 cents per share, a year earlier.
Excluding items, the company earned 21 cents per share.
Net sales rose more than 19 percent to $2.65 billion.
